HUBEI LONGXIANG PHARMACEUTICAL TECH.CO.,LTD.
Hubei Longxiang Pharmaceutical Technology Co., Ltd.
Hubei Longxiang Pharmaceutical Technology Co., Ltd. foi fundada em janeiro de 2008 com um capital social de 122 milhões de yuans. O acionista controlador é Tianjin Ruipu Biotechnology Co., Ltd. (código de ações: 300119). A Longxiang Pharmaceutical foi listada no Novo Terceiro Conselho em abril de 2017, código de ações: 871082. Possui mais de 340 funcionários e ativos totais de 560 milhões de yuans.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Wuxue, China
- Website
- https://www.lxpharm.com
- Categories
- Fabricação farmacêutica, Produtos químicos e plásticos, Produtos veterinários e saúde animal
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
- domain-registered (green), checked 2026-08-09 Domain registry record
- debarment-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- lei-lapsed (amber), checked 2026-08-09 GLEIF
- sanctions-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)